Obiltoxaximab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB05336 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | postinfectious vasculitis | KG + DL |
| 2 | post-infectious syndrome | KG + DL |
| 3 | post-bacterial disorder | KG + DL |
| 4 | infective urethral stricture | KG + DL |
| 5 | otitis externa | KG + DL |
| 6 | Chagas cardiomyopathy | KG + DL |
| 7 | infection-related hemolytic uremic syndrome | KG + DL |
| 8 | drug-induced osteoporosis | KG + DL |
| 9 | parasitic eyelid infestation | KG + DL |
| 10 | ulcerative blepharitis | KG + DL |
| 11 | blepharoconjunctivitis | KG + DL |
| 12 | noninfectious dermatoses of eyelid | KG + DL |
| 13 | orbital cellulitis | KG + DL |
| 14 | skin disease caused by infection | KG + DL |
| 15 | ophthalmic herpes zoster | KG + DL |
| 16 | infectious mononucleosis | KG + DL |
| 17 | trachoma | KG + DL |
| 18 | infectious otitis interna | KG + DL |
| 19 | pityriasis simplex | KG + DL |
| 20 | tinea corporis | KG + DL |
| 21 | chronic fungal otitis externa | KG + DL |
| 22 | geniculate herpes zoster | KG + DL |
| 23 | rosacea conjunctivitis | KG + DL |
| 24 | infectious anterior uveitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.